NEUROBEHAVIORAL HOSPITAL LLC — History
CCN 154065 | 3-year financial timeline | COVID resilience: 23/100
🛡️ Public data only — no PHI permitted on this instance.
$16M
Latest Revenue (FY2022)
-7.6%
Revenue CAGR (3yr)
1.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $18M | $17M | $16M | -7.3% | -7.6% |
| Operating Expenses | $16M | $16M | $15M | -1.2% | -0.4% |
| Operating Margin | 15.1% | 7.4% | 1.4% | -81.6% | -69.9% |
| Net Income | $3M | $1M | $0M | -82.9% | -72.2% |
| Licensed Beds | 70 | 70 | 70 | +0.0% | +0.0% |
| Total Patient Days | 21,306 | 21,564 | 20,878 | -3.2% | -1.0% |
| Medicare Day % | 72% | 50% | 32% | -35.5% | -33.0% |
| Medicaid Day % | 13% | 21% | 4% | -78.5% | -41.5% |
COVID Impact & Recovery
Resilience Score: 23/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -14.6% ($18M → $16M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-7.6%
This Hospital
+7.6%
State Avg
Latest Margin
1.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $14M | -5.5% |
| FY2024 (proj) | $13M | -12.4% |
| FY2025 (proj) | $12M | -19.3% |